Back to results
US 7,598,252 B2Granted
Compounds specific to adenosine A, receptors and uses thereof
AssigneeOSI Pharmaceuticals, Inc.
InventorsArlindo L. Castelhano, Bryan McKibben, David J. Witter
Life of this patent
Estimating the term…
Abstract
This invention pertains to compounds which specifically inhibit the adenosine A1 receptor and the use of these compounds to treat a disease associated with A1 adenosine receptors in a subject.
Claims6
A pharmaceutical composition comprising the compound having the structure:
- or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.